Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · IEX Real-Time Price · USD
0.653
-0.007 (-1.05%)
Jul 22, 2024, 9:41 AM EDT - Market open
Aptose Biosciences Employees
As of December 31, 2023, Aptose Biosciences had 36 total employees, including 35 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
36
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,310,306
Market Cap
11.79M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Novo Integrated Sciences | 230 |
Ontrak | 104 |
STRATA Skin Sciences | 99 |
Check-Cap | 85 |
Lumos Pharma | 33 |
Imunon | 33 |
Purple Biotech | 20 |
NEXGEL | 19 |
APTO News
- 2 days ago - Aptose Announces Receipt of Deficiency Notice from Nasdaq - GlobeNewsWire
- 4 weeks ago - Aptose Announces Results from Annual and Special Meeting of Shareholders - GlobeNewsWire
- 5 weeks ago - Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress - GlobeNewsWire
- 6 weeks ago - Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 7 weeks ago - Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - Aptose Reports Results for the First Quarter 2024 - GlobeNewsWire
- 2 months ago - Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024 - GlobeNewsWire
- 4 months ago - Aptose Reports Results for the Fourth Quarter and Full Year 2023 - GlobeNewsWire